Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Eye Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00078091
What this trial is testing

Genetics and Clinical Characteristics of Bardet-Biedl Syndrome

Who this might be right for
Bardet-Biedl Syndrome
National Human Genome Research Institute (NHGRI) 194
Testing effectiveness (Phase 2)Active Not RecruitingNCT06300476
What this trial is testing

Safety and Efficacy of a Single Subretinal Injection of JWK006 Gene Therapy in Subjects With Stargardt Disease(STGD1)

Who this might be right for
Stargardt Disease 1
West China Hospital 9
Not applicableStudy completedNCT04495218
What this trial is testing

NGS Panel of Incomplete Forms of Ocular Albinism

Who this might be right for
Albinism, Ocular
University Hospital, Bordeaux 53
Not applicableWithdrawnNCT03399825
What this trial is testing

Optical Coherence Tomography Angiography (OCT-A) in Children (≥ 6 <14 Years of Age)

Who this might be right for
Retinopathy of PrematurityDiabetic Retinopathy
Insel Gruppe AG, University Hospital Bern
Not applicableLooking for participantsNCT05963191
What this trial is testing

CAD-EYE System for the Detection of Neoplastic Lesions in Patients With Lynch Syndrome

Who this might be right for
Lynch Syndrome
PERROD Guillaume 272
Not applicableStudy completedNCT02683317
What this trial is testing

Enteral Administration of Docosahexaenoic Acid to Prevent Retinopathy of Prematurity

Who this might be right for
Retinopathy of Prematurity
Coordinación de Investigación en Salud, Mexico 110
Post-approval studies (Phase 4)Study completedNCT01997489
What this trial is testing

Ophthalmic Findings During 10-year Enzyme Substitution of Danish Fabry Patients.

Who this might be right for
Fabry Disease
Rigshospitalet, Denmark 39
Large-scale testing (Phase 3)Study completedNCT05176639
What this trial is testing

A Safety, Tolerability, and Efficacy Study of Veligrotug (VRDN 001) in Participants With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 113
Testing effectiveness (Phase 2)Active Not RecruitingNCT01736592
What this trial is testing

Phase I/II Follow-up Study of SAR422459 in Patients With Stargardt's Macular Degeneration

Who this might be right for
Stargardt's Disease
Sanofi 27
Testing effectiveness (Phase 2)WithdrawnNCT06087731
What this trial is testing

Efficacy and Safety of Tocilizumab for TAO

Who this might be right for
TocilizumabThyroid Associated Ophthalmopathy
Sun Yat-sen University
Testing effectiveness (Phase 2)Looking for participantsNCT03083431
What this trial is testing

Oral Propranolol for Prevention of Threshold Retinopathy of Prematurity

Who this might be right for
Retinopathy of Prematurity
University of Zurich 276
Large-scale testing (Phase 3)Study completedNCT00790400
What this trial is testing

Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)

Who this might be right for
Tuberous Sclerosis Complex (TSC)Lymphangioleiomyomatosis (LAM)
Novartis Pharmaceuticals 118
Not applicableLooking for participantsNCT06881771
What this trial is testing

FECD-TRACE: Fuchs' Endothelial Corneal Dystrophy TRAjectory and Correlation With Genotype in the United Kingdom

Who this might be right for
Fuchs DystrophyFuchs' Endothelial DystrophyFuchs' Endothelial Corneal Dystrophy of Bilateral Eyes+2 more
University College, London 500
Large-scale testing (Phase 3)Active Not RecruitingNCT06625411
What this trial is testing

An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Active Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 132
Testing effectiveness (Phase 2)WithdrawnNCT00514982
What this trial is testing

Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome

Who this might be right for
Hermanski-Pudlak SyndromeColitisCytokines+2 more
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableEnded earlyNCT02584413
What this trial is testing

Hypotonia and Neurofibromatosis Type 1 (NF1) Glioma

Who this might be right for
Neurofibromatosis Type 1
Washington University School of Medicine 29
Not applicableLooking for participantsNCT05584488
What this trial is testing

Allergy and Immunology Natural History Study

Who this might be right for
Immune DeficiencyImmune Dysregulation DisorderAllergic Inflammation
Columbia University 10,000
Not applicableStudy completedNCT05152862
What this trial is testing

Improve Screening Criteria for Retinopathy of Prematurity in Two French Center

Who this might be right for
Retinopathy of Prematurity
Centre Hospitalier Sud Francilien 886
Testing effectiveness (Phase 2)Study completedNCT02077361
What this trial is testing

An Open Label Clinical Trial of Retinal Gene Therapy for Choroideremia

Who this might be right for
Choroideremia
University of Alberta 6
Post-approval studies (Phase 4)Study completedNCT00716586
What this trial is testing

Treatment of Cystoid Macular Edema in Patients With Retinal Degeneration

Who this might be right for
Retinal Degenerations
University of Illinois at Chicago 44
Next Page